Guaifenesin And Dextromethorphan Hbr Tablet, Extended Release
NDC Package 51316-009-01
Package Information
Guaifenesin And Dextromethorphan Hbr tablets is do not crush, chew, or break tablet take with a full glass of water this product can be administered without regard for timing of meals children under 12 years of age: do not useFor 600 mg/30 mg:adults and children 12 years and older: 1 or 2 tablets every 12 hours; not more than 4 tablets in 24 hours. This formulation utilizes a tablet, extended release delivery system. Marketed by Cvs Pharmacy, this product is identified by NDC 51316-009 and is authorized under FDA application ANDA217340.
Identification & Billing
- RxCUI: 1298324 - guaiFENesin 600 MG / dextromethorphan HBr 30 MG 12HR Extended Release Oral Tablet
- RxCUI: 1298324 - 12 HR dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG Extended Release Oral Tablet
- RxCUI: 1298324 - dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG 12 HR Extended Release Oral Tablet
Clinical Specifications
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 51316 - Cvs Pharmacy
- 51316-009 - Guaifenesin And Dextromethorphan Hbr
- 51316-009-01 - 5 BLISTER PACK in 1 CARTON / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
- 51316-009 - Guaifenesin And Dextromethorphan Hbr
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51316-009-01 identifies a specific commercial package of 5 blister pack in 1 carton / 20 tablet, extended release in 1 blister pack of Guaifenesin And Dextromethorphan Hbr, a human over the counter drug labeled by Cvs Pharmacy. This tablet, extended release is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs Pharmacy on August 15, 2023. The current certification is valid through December 31, 2026.
How is this Cvs Pharmacy product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51316000901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.